Association between Gly241Arg ICAM-1 gene polymorphism and serum sICAM-1 concentration in the Stanislas cohort

European Journal of Human Genetics

Volumn 11, Issue 9, 2003, Pages 679-686

  Ponthieux, Anne ^a,b   Lambert, Daniel ^a,b   Herbeth, Bernard ^a,b   Droesch, Suzanne ^a,b   Pfister, Michèle ^a,b   Visvikis, Sophie ^a,b  

^a INSERM   (France)

^b Centre de Medecine Preventive   (France)

Author keywords

Healthy population; ICAM 1; Polymorphism

Indexed keywords

ALKALINE PHOSPHATASE; ARGININE; ASPARTATE AMINOTRANSFERASE; BIOCHEMICAL MARKER; CD11B ANTIGEN; CELL ADHESION MOLECULE; GLYCINE; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6;

ADOLESCENT; ADULT; AGE; AGED; ALLELE; ARTICLE; BLOOD LEVEL; CELL ACTIVATION; CELL INTERACTION; CHILD; CODOMINANCE; CODON; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; COVARIANCE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXON; EXTRACTION; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; LEUKOCYTE; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE; ALLELES; ANALYSIS OF VARIANCE; ASPARTATE AMINOTRANSFERASES; CHILD; FEMALE; HUMANS; INSULIN RESISTANCE; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MIDDLE AGED; MODELS, GENETIC; POLYMORPHISM, GENETIC; SMOKING;

EID: 0141813344     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201033     Document Type: Article

References (63)

1. Springer TA: Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995; 57: 827-872.
2. Budnik A, Grewe M, Gyufko K, Krutmann J: Analysis of the production of soluble ICAM-1 molecules by human cells. Exp Hematol 1996; 24: 352-359.
3. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD: A form of circulating ICAM-1 in human serum. J Immunol 1991; 147: 3788-3793.
4. Sfikakis PP, Tsokos GC: Clinical use of the measurement of soluble cell adhesion molecules in patients with autoimmune rheumatic diseases. Clin Diagn Lab Immunol 1997; 4: 241-246.
5. Kelly KA: Modulation of leukocyte-endothelial cell interactions by infectious agents. Bull Inst Pasteur 1997; 95: 147-159.
6. Labarrere CA, Nelson DR, Park JW: Pathologic markers of allograft arteriopathy: insight into the pathophysiology of cardiac allograft chronic rejection. Curr Opin Cardiol 2001; 16: 110-117.
7. Banks RE, Gearing AJ, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ: Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 1993; 68: 122-124.
8. Eppihimer MJ: The role of leukocyte-endothelial cell adhesion in cardiovascular disease. Pathophysiology 1998; 5: 167-184.
9. Vora DK, Rosenbloom CL, Beaudet AL, Cottingham RW: Polymorphisms and linkage analysis for ICAM-1 and the selectin gene cluster. Genomics 1994; 21: 473-477.
10. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA: Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988; 52: 925-933.
11. Braun C, Zahn R, Martin K, Albert E, Folwaczny C: Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardeless of the p-ANCA status. Clin Immunol 2001; 101: 357-360.
12. Yang H: Analysis of ICAM-1 gene polymorphism in immunologic subsets of inflammatory bowel disease. Exp Clin Immunogenet 1997; 14: 214-225.
13. Macchioni P, Boiardi L, Casali B, Nicoli D, Farnetti E, Salvarani C: Intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in Italian patients with rheumatoid arthritis. Clin Exp Rheumatol 2000; 18: 553-558.
14. Salvarani C, Casali B, Boiardi L et al: Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity. J Rheumatol 2000; 27: 1215-1221.
15. Boiardi L, Salvarani C, Casali B et al: Intercellular adhesion molecule-1 gene polymorphisms in Behcet's Disease. J Rheumatol 2001; 28: 1283-1287.
16. Amoli MM, Shelley E, Mattey DL et al: Lack of association between intercellular adhesion molecule-1 gene polymorphisms and giant cell arteritis. J Rheumatol 2001; 28: 1600-1604.
17. Mycko MP, Kwinkowski M, Tronczynska E, Szymanska B, Selmaj KW: Multiple sclerosis: the increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann Neurol 1998; 44: 70-75.
18. Hirv K, Seyfarth M, Uibo R et al: Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers. Scand J Gastroenterol 1999; 34: 1025-1032.
19. Amoli MM, Shelley E, Mattey Dl et al: Intercellular adhesion molecule-1 gene polymorphisms in isolated polymyalgia rheumatica. J Rheumatol 2002; 29: 502-504.
20. Yang H, Vora DK, Targan SR, Toyoda H, Beaudet Al, Rotter JI: Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease. Gastroenterology 1995; 109: 440-448.
21. Yang H: Analysis of ICAM-1 gene polymorphism in immunologic subsets of inflammatory bowel disease. Exp Clin Immunogenet 1997; 14: 241-325.
22. Amoli MM, Mattey DL, Calvino MC et al: Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complications in Henoch-Schonlein purpura. J Rheumatol 2001; 28: 1014-1018.
23. Verity DH, Vaughan RW, Kondeatis E et al: Intercellular adhesion molecule-1 gene polymorphisms in Behcet's disease. Eur J Immunogenet 2000; 27: 73-76.
24. Marrosu MG, Schirru L, Fadda E et al: ICAM-1 gene is not associated with multiple sclerosis in sardinian patients. J Neurol 2000; 247: 677-680.
25. Wenzel K, Ernst M, Rohde K, Baumann G, Speer A: DNA polymorphisms in adhesion molecule genes - a new risk factor for early atherosclerosis. Hum Genet 1996; 97: 15-20.
26. Gomez-Scotto E, Seigneur M, Renard M, Houbouyan-Reveillard LL, Boisseau MR: Interest in variations in soluble ICAM-1 plasma levels. From physiology to clinical application. J Mal Vasc 2000; 25: 156-165.
27. Siest G, Visvikis S, Herbeth B et al: Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: the Stanislas cohort. Clin Chem Lab Med 1998; 36: 35-42.
28. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
29. Cheng S, Pallaud C, Grow MA et al: A multilocus genotyping assay for cardiovascular disease. Clin Chem Lab Med 1998; 36: 561-566.
30. Hanley JA, Negassa A, Edwardes MD, Forrester JE: Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 2003; 157: 364-375.
31. Demerath E, Towne B, Blangero J, Siervogel RM: The relationship of soluble ICAM-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women. Ann Hum Biol 2001; 28: 664-678.
32. Rohde LE, Lee RT, Rivero J et al: Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 1998; 18: 1765-1770.
33. Rohde LE, Hennekens CH, Ridker PM: Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men. Arterioscler Thromb Vasc Biol 1999; 19: 1595-1599.
34. Hwang SJ, Ballantyne CM, Sharrett AR et al: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997; 96: 4219-4225.
35. Waron C, Whittaker S, Smith N, Vora AJ, Brown KA: Il-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin Exp Immunol 1996; 105: 112-119.
36. Romano M, Sironi M, Toniatti C et al: Role of Il-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997; 6: 315-325.
37. McLaren AJ, Marshall SE, Haldar NA et al: Adhesion molecule polymorphisms in chronic renal allograft failure. Kidney Int 1999; 55: 1977-1982.
38. Diamond MS, Staunton DE, Marlin SD, Springer TA: Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 1991; 65: 961-971.
39. Smith CW, Entman ML, Lane CL et al: Adherence of neutrophils to canine cardiac myocytes in vitro is dependent on intercellular adhesion molecule-1. J Clin Invest 1991; 88: 1216-1223.
40. Ballantyne CM, Kozak CA, O'Brien WE, Beaudet AL: Assignment of the gene for intercellular adhesion molecule-1 (Icam-1) to proximal mouse chromosome 9. Genomics 1991; 9: 547-550.
41. Kita Y, Takashi T, Iigo Y, Tamatani T, Miyasaka M, Horiuchi T: Sequence and expression of rat ICAM-1. Biochim Biophys Acta 1992; 1131: 108-110.
42. Hubbard AK, Rothlein R: Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med 2000; 28: 1379-1386.
43. Clayton A, Evans RA, Pettit E, Hallett M, Williams JD, Steadman R: Cellular activation through the ligation of intercellular adhesion molecule-1. J Cell Sci 1998; 111: 443-453.
44. Nash MC, Wade AM, Shah V, Dillon MJ: Normal levels of soluble E-selectin, soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease with age. Clin Exp Immunol 1996; 103: 167-170.
45. Andrys C, Pozler O, Krejsek J, Derner V, Drahosova M, Kopecky O: Serum soluble adhesion molecules (sICAM-1, sVCAM-1 and sE-selectin) in healthy school aged children and adults. Acta Med 2000; 43: 103-106.
46. Sack U, Burkhardt U, Borte M, Schadlich H, Berg K, Emmrich F: Age-dependent levels of select immunological mediators in sera of healthy children. Clin Diagn Lab Immunol 1998; 5: 28-32.
47. Ohta T, Saku K, Takata K, Adachi N: Soluble vascular cell-adhesion molecule-1 and soluble intercellular adhesion molecule-1 correlate with lipid and apolipoprotein risk factors for coronary artery disease in children. Eur J Pediatr 1999; 158: 592-598.
48. Blann AD, Daly RJ, Amiral J: The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol 1996; 92: 498-500.
49. Seeger H, Wallwiener D, Mueck AO: Lipid-independent effects of an estrogen-statin combination: inhibition of expression of adhesion molecules and plasminogen activator inhibitor-I in human endothelial cell cultures. Climacteric 2001; 4: 209-214.
50. Caulin-Glaser T, Watson CA, Pardi R, Bender JR: Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 1996; 98: 36-42.
51. Oger E, Alhenc-Gelas M, Plu-Bureau G et al: Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users. Thromb Res 2001; 101: 35-43.
52. Koh KK, Jin DK, Yang SH et al: Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women. Circulation 2001; 103: 1961-1966.
53. Zanger D, Yang BK, Ardans J et al: Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management. J Am Coll Cardiol. 2000; 36: 1797-1802.
54. Guzic-Salobir B, Keber I, Seljeflot I, Arnesen H, Vrabic L: Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women. J Intern Med 2001; 250: 508-515.
55. Koundouros E, Odell E, Coward P, Wilson R, Palmer RM: Soluble adhesion molecules in serum of smokers and non-smokers, with and without periodontitis. J Periodontal Res 1996; 31: 596-599.
56. Blann AD, Steele C, McCollum CN: The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thromb Res 1997; 85: 433-438.
57. Bergmann S, Siekmeier R, Mis C, Jaross W: Even moderate cigarette smoking influences the pattern of circulating monocytes and the concentration of sICAM-1. Respir Physiol 1998; 114: 269-275.
58. Bermudez EA, Rifai N, Buring JE, Manson JE, Ridker PM: Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 2002; 89: 1117-1119.
59. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J: Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351: 88-92.
60. Shen Y, Rattan V, Sultana C, Kalra VK: Cigarette smoke condensate-induced adhesion molecule expression and transendothelial migration of monocytes. Am J Physiol 1996; 270: H1624-H1633.
61. Furie MB, Raffanello JA, Gergel EI, Lisinski TJ, Horb LD: Extracts of smokeless tobacco induce pro-inflammatory changes in cultured human vascular endothelial cells. Immunopharmacology 2000; 47: 13-23.
62. Chen N-G, Holmes M, Reaven GM: Relationship between insulin resistance, soluble adhesion molecules and mononuclear cell binding in healthy volunteers. J Clin Metab Endocrinol 1999; 84: 3485-3489.
63. Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L: Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Metab Endocrinol 2002; 87: 144-147.